Rubric Capital Management
Superinvestor profile · Rank #40 by reported 13F value (2026 Q2 filers) · CIK 0001687509 · All profiles
Founded 2016New York, New York, United StatesValue-oriented long/short equity — deep-value longs with an alpha short book, low net exposureKey person: David Rosen
Reported 13F value
$10.9B
Period 2026-06-30 · Filed 2026-08-14
Positions
87
Top 10 = 46.4% of value
Clone CAGR (full window)
+12.2%
2017-02-03 → 2026-10-02 · cumulative +203%
SPY CAGR (same window)
+15.2%
Cumulative +291%
Max drawdown (monthly)
-51%
Month-end values, approximate
Latest-quarter activity
18 new · 14 exited
35 increased · 10 decreased
Hypothetical clone — not this fund's returns. The performance on this page replicates only the long U.S. equity positions disclosed on this manager's Form 13F filings, rebalanced on filing dates at disclosed weights with dividend-adjusted prices. It excludes shorts, bonds, cash, non-U.S. listings, private holdings, leverage and fees. Treat it as a measure of how the disclosed stock picks performed, never as the fund's track record. Evidence: filing-by-filing dossier (PDF) · Methodology (PDF)
Clone performance
| Window | Clone CAGR | Note |
|---|---|---|
| Full window (2017-02-03 → 2026-10-02, 39 filings) | +12.15% | Cumulative +202.8% vs SPY +290.7% |
| Trailing 10Y | — | |
| Trailing 5Y | +15.88% | |
| Trailing 3Y | +25.58% | |
| Trailing 1Y | +4.86% |
Top holdings — 2026 Q2 filing
| Ticker | Company | Weight | Reported value |
|---|---|---|---|
| TLN | Talen Energy Corp | 12.70% | $1.4B |
| FTAI | Ftai Aviation Ltd | 7.45% | $812M |
| VTRS | Viatris Inc | 4.98% | $543M |
| TEVA | Teva Pharmaceutical Inds Ltd | 4.84% | $528M |
| GLNG | Golar Lng Ltd | 4.20% | $457M |
| VST | Vistra Corp | 2.61% | $285M |
| TAC | Transalta Corp | 2.57% | $280M |
| FLR | Fluor Corp | 2.41% | $263M |
| KNSA | Kiniksa Pharmaceuticals Intl | 2.35% | $256M |
| BGC | Bgc Group Inc | 2.33% | $254M |
As reported on the 2026-06-30 Form 13F (filed 2026-08-14). Full holdings and quarter changes: holdings page.
Filing history in this profile
Every clone input traces to one of these SEC filings. 60.6% of the latest filing's reported value is covered by our price history; the remainder is mostly non-U.S. listings, recent IPOs or delisted names and is excluded from the clone.
Background (founded / HQ / style) source: https://www.insidermonkey.com/hedge-fund/rubric-capital-management/968/ — Founded by David Efrain Rosen, former Point72 / S.A.C. Capital portfolio manager; master fund inception 5 Oct 2016.